Asston Pharmaceu

When is the next results date for Asston Pharmaceu?

Asston Pharmaceu is scheduled to announce its results on 14 November 2025.

Asston Pharmaceu is scheduled to declare its results on 14 November 2025.

How has been the historical performance of Asston Pharmaceu?

Asston Pharmaceu experienced significant growth from March 2024 to March 2025, with net sales rising to 25.04 Cr from 15.59 Cr, and profit after tax increasing to 4.33 Cr from 1.36 Cr. Key metrics such as EPS improved to 6.91 and operating profit margin rose to 24.64%, indicating a strengthening financial position.

Answer:<BR>The historical performance of Asston Pharmaceu shows significant growth in various financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>Asston Pharmaceu reported net sales of 25.04 Cr in March 2025, a notable increase from 15.59 Cr in March 2024. Total operating income also rose to 25.04 Cr from 15.59 Cr, driven by an increase in raw material costs to 14.13 Cr from 9.75 Cr. The total expenditure, excluding depreciation, increased to 18.87 Cr from 13.04 Cr, resulting in an operating profit (PBDIT) of 6.74 Cr, up from 2.80 Cr. Profit before tax surged to 5.70 Cr from 1.82 Cr, leading to a profit after tax of 4.33 Cr, compared to 1.36 Cr the previous year. The earnings per share (EPS) improved significantly to 6.91 from 2.18, while the operating profit margin increased to 24.64% from 16.36%. The total assets of the company grew to 28.10 Cr from 20.70 Cr, with total liabilities also rising to 28.10 Cr from 20.70 Cr. The book value per share adjusted increased to 17.6 from 11.45, reflecting the company's strengthening financial position.

Is Asston Pharmaceu overvalued or undervalued?

As of November 26, 2025, Asston Pharmaceu is considered overvalued with a PE ratio of 22.11, a price-to-book value of 2.20, and an EV to EBITDA ratio of 16.35, despite outperforming the Sensex with a 1-week return of 17.65%.

As of 26 November 2025, Asston Pharmaceu's valuation grade has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued, with a price-to-earnings (PE) ratio of 22.11, a price-to-book value of 2.20, and an EV to EBITDA ratio of 16.35. These metrics suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Asston Pharmaceu's PE ratio is lower than that of Sun Pharma (37.53) and Divi's Lab (69.71), both categorized as expensive, while it is slightly higher than Cipla (22.59) and Dr. Reddy's Labs (18.02), which are viewed as attractive. The company's recent stock performance has outpaced the Sensex, with a 1-week return of 17.65% compared to the Sensex's 0.50%, reinforcing the notion of overvaluation in the current market context.

Why is Asston Pharmaceuticals Ltd falling/rising?

As of 17-Mar, Asston Pharmaceuticals Ltd's stock price is Rs 74.00, down 3.9%, reflecting a consistent decline with a 9.76% drop over the past week and 10.34% year-to-date. The stock is underperforming its sector and experiencing reduced investor participation, indicating a lack of confidence and downward pressure.

As of 17-Mar, Asston Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 74.00, which reflects a decrease of Rs 3.0 or 3.9%. This drop is evident as the stock opened with a loss of 3.9% today and has not traded above this opening price, indicating a lack of upward momentum. The stock has underperformed its sector by 4.18% today, further highlighting its struggles in the market.<BR><BR>In terms of performance over various periods, the stock has shown a significant decline of 9.76% over the past week and 8.53% over the past month. Year-to-date, it has decreased by 10.34%, which is slightly better than the Sensex's decline of 10.74%. However, the overall trend indicates a consistent downward movement, as the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.<BR><BR>Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 41.18% compared to the 5-day average. This reduction in trading activity suggests a lack of confidence among investors, contributing to the stock's decline. Overall, the combination of poor performance metrics, low trading volume, and underperformance against benchmarks indicates that Asston Pharmaceuticals Ltd is currently facing downward pressure in its stock price.

Why is Asston Pharmaceuticals Ltd falling/rising?

As of 18-Mar, Asston Pharmaceuticals Ltd's stock price is currently at Rs. 77.00, reflecting a 4.05% increase today. However, the stock has declined over the past week and month, hit a 52-week low earlier, and shows signs of a longer-term downtrend, warranting caution for investors.

As of 18-Mar, Asston Pharmaceuticals Ltd's stock price is rising, currently at Rs. 77.00, which reflects a change of Rs. 3.0 or 4.05% increase. This rise is notable as the stock has outperformed its sector by 3.78% today. The stock reached an intraday high of Rs. 77, indicating positive momentum during the trading session. <BR><BR>However, it is important to consider the broader context of the stock's performance. Over the past week, the stock has declined by 1.91%, and it has seen a more significant drop of 6.10% over the past month. Additionally, the stock hit a new 52-week low of Rs. 70 earlier today, which suggests volatility and potential investor concerns. <BR><BR>Despite the current rise, the stock is trading below its moving averages across various time frames (5-day, 20-day, 50-day, 100-day, and 200-day), indicating a longer-term downtrend. Furthermore, there has been a significant decrease in investor participation, with delivery volume dropping by 70.59% compared to the 5-day average. <BR><BR>In summary, while the stock is experiencing a rise today, the overall trend and investor activity suggest caution, as the stock has faced considerable downward pressure in recent weeks.

Why is Asston Pharmaceuticals Ltd falling/rising?

As of 19-Mar, Asston Pharmaceuticals Ltd's stock price is at Rs 72.50, down 2.59%, with significant declines over the past week and month, underperforming the Sensex. The stock is trading below all key moving averages and is close to its 52-week low, indicating a bearish trend despite a recent increase in delivery volume.

As of 19-Mar, Asston Pharmaceuticals Ltd's stock price is falling, currently at Rs 72.50, which represents a decrease of Rs 1.93 or 2.59%. This decline is reflected in the stock's performance over various periods, showing a 7.05% drop over the past week and a 12.34% decrease over the past month, both of which are worse than the benchmark Sensex's declines of 2.40% and 10.05%, respectively. <BR><BR>Additionally, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. The stock is also close to its 52-week low, being only 3.45% away from Rs 70. Today's performance has underperformed the sector by 0.44%, and the overall action in the Pharmaceuticals & Drugs sector has seen a decline of 2.13%. <BR><BR>Despite a rise in delivery volume by 36.36% on March 18, indicating increased investor participation, the overall market sentiment and the stock's performance metrics suggest a continued downward trend.

Why is Asston Pharmaceuticals Ltd falling/rising?

As of 20-Mar, Asston Pharmaceuticals Ltd's stock price is currently Rs 70.15, reflecting a 3.24% decrease. The stock has significantly underperformed, with a year-to-date decline of 15.00%, and is trading below all key moving averages, indicating a bearish trend.

As of 20-Mar, Asston Pharmaceuticals Ltd's stock price is falling, currently at Rs 70.15, which reflects a decrease of Rs 2.35 or 3.24%. The stock has been underperforming significantly, with a 1-week decline of 6.47% compared to a negligible drop of 0.04% in the Sensex. Over the past month, the stock has fallen by 14.45%, while the benchmark index has decreased by 10.00%. Year-to-date, the stock is down 15.00%, contrasting with a 12.54% decline in the Sensex.<BR><BR>Today, the stock opened with a gain of 6.9%, reaching an intraday high of Rs 77.5, but quickly fell to a low of Rs 70.1, indicating high volatility with an intraday fluctuation of 5.01%. The stock has been losing for the last two days, accumulating a total decline of 5.75% during this period. Additionally, it is trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), which suggests a bearish trend.<BR><BR>Despite a rise in investor participation, with delivery volume increasing by 25% on 19 March, the overall performance today has underperformed the sector by 4.94%. The stock is also very close to its 52-week low, being only 0.21% away from that point. These factors collectively contribute to the ongoing decline in Asston Pharmaceuticals Ltd's stock price.

Why is Asston Pharmaceuticals Ltd falling/rising?

As of 23-Mar, Asston Pharmaceuticals Ltd's stock price is Rs. 68.15, down 2.85%, and has hit a new 52-week low. The stock has underperformed significantly against the Sensex and the overall sector, despite a slight increase in investor participation.

As of 23-Mar, Asston Pharmaceuticals Ltd's stock price is falling, currently at Rs. 68.15, which reflects a decrease of Rs. 2.0 or 2.85%. The stock has been on a downward trend, having lost 8.44% over the last three days and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has hit a new 52-week low today, indicating a significant decline in value. <BR><BR>In terms of performance against the benchmark, the stock has underperformed, with a 1-week decline of 11.49% compared to the Sensex's 3.72% drop and a 1-month decline of 16.89% versus the Sensex's 12.72% decline. The overall sector, Pharmaceuticals & Drugs, has also seen a decrease of 3.58%, which may be contributing to the stock's poor performance. <BR><BR>Despite a slight increase in investor participation, with delivery volume rising by 55.17% against the 5-day average, the overall market sentiment appears negative, leading to the stock's continued decline.

Why is Asston Pharmaceuticals Ltd falling/rising?

As of 24-Mar, Asston Pharmaceuticals Ltd's stock price is rising to Rs 70.00, marking a 2.67% increase after three days of decline, indicating a potential trend reversal. Despite this rise, the stock remains below its moving averages, though increased investor participation suggests growing interest.

As of 24-Mar, Asston Pharmaceuticals Ltd's stock price is rising, currently at Rs 70.00, reflecting a change of Rs 1.82 or 2.67% increase. This upward movement is notable as it comes after three consecutive days of decline, indicating a potential trend reversal. Today, the stock opened with a significant gain of 10.74%, reaching an intraday high of Rs 75.5. Additionally, the stock has outperformed its sector by 1.55%, suggesting positive market sentiment relative to its peers.<BR><BR>Despite the recent rise, it is important to note that the stock is still trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically indicates a bearish trend. However, there has been a rise in investor participation, with delivery volume increasing by 36.36% compared to the 5-day average, suggesting growing interest among investors.<BR><BR>Overall, the combination of a significant opening gain, a potential trend reversal after previous declines, and increased investor participation are key factors contributing to the current rise in Asston Pharmaceuticals Ltd's stock price.

Why is Asston Pharmaceuticals Ltd falling/rising?

As of 25-Mar, Asston Pharmaceuticals Ltd's stock price is at 70.00, unchanged from the previous session. The stock has seen significant declines over various periods, indicating a bearish trend and underperformance compared to its sector and the broader market.

As of 25-Mar, Asston Pharmaceuticals Ltd's stock price is currently at 70.00, showing no change from the previous trading session. The stock has experienced a significant decline over various periods, with a 1-week drop of 5.95% and a 1-month decrease of 14.63%. Year-to-date, the stock has fallen by 15.18%, which is notably worse than the Sensex's decline of 11.67% during the same timeframe.<BR><BR>The stock is currently trading close to its 52-week low, being only 2.86% above the low of Rs 68. Additionally, it has underperformed its sector by 1.89% today. The stock is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a decrease in investor participation, with delivery volume falling by 7.89% compared to the 5-day average. <BR><BR>These factors collectively suggest that Asston Pharmaceuticals Ltd is experiencing a downward trend in its stock price.

Which are the latest news on Asston Pharmaceu?